GlassScriptPhysician profile
La Genia Dpm Mitchell Smith
NPI 1467444570
$2,088.97
in general payments reported to CMS, 2019-2025
34 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $126 · 2021: $457 · 2022: $345 · 2023: $330 · 2024: $58.11 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $333.26 | 2019-2025 | Stravix, Grafix |
| Paratek Pharmaceuticals, INC. | $311.67 | 2021-2025 | Nuzyra |
| Grt US Holding, INC. | $212.97 | 2020-2022 | |
| Melinta Therapeutics, LLC | $113.77 | 2019-2022 | |
| Nevro Corp. | $111.50 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $110.87 | 2019-2022 | |
| Bioventus LLC | $68.29 | 2019-2023 | Theragenesis Bilayer Wound Matrix |
| Biocomposites INC | $61.33 | 2021 | |
| Kerecis Limited | $60.51 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $56.26 | 2022-2023 | Seglentis |
| Amniox Medical, INC. | $48.99 | 2019 | |
| Averitas Pharma INC. | $45.66 | 2023 | Qutenza |
| Organogenesis INC. | $42.71 | 2019 | |
| Abbvie INC. | $42.58 | 2023 | |
| Zimvie INC. | $35.74 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $35.61 | 2020 | |
| Treace Medical Concepts, INC. | $34.50 | 2023-2025 | |
| Integra Lifesciences Corporation | $32.40 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.35 | 2021-2025 | Cabtreo, Siliq, Jublia |
| Osteomed LLC | $28.58 | 2019 | |
| Triad Life Sciences INC. | $24.34 | 2022 | |
| Wright Medical Technology, INC. | $24.05 | 2019 | |
| Acera Surgical, INC. | $23.93 | 2019 | |
| Abbott Laboratories | $22.66 | 2021 | |
| Nabriva Therapeutics, Plc | $20.47 | 2022 | |
| Innovation Technologies INC | $19.72 | 2025 | Irrisept |
| Aroa Biosurgery Incorporated | $19.64 | 2022 | |
| Normatec Industries, LP | $19.33 | 2019 | |
| Sebela Pharmaceuticals INC. | $17.82 | 2020 | |
| Depuy Synthes Sales INC. | $17.63 | 2024 | |
| Stryker Corporation | $16.91 | 2021 | |
| Convatec INC. | $16.22 | 2021 | |
| Reapplix INC. | $15.05 | 2022 | |
| Hydrofera LLC | $13.65 | 2023 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw La Genia Mitchell Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.